Compare MaxLinear Inc. Common Stock (MXL) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MaxLinear Inc. Common Stock vs Nuvation Bio Inc. Class A Common Stock — how do they compare? MaxLinear Inc. Common Stock trades at $96.86 (market cap $8.50B), while Nuvation Bio Inc. Class A Common Stock trades at $5.03 (market cap $1.74B). The key difference: MaxLinear Inc. Common Stock is far larger — about 4.9× Nuvation Bio Inc. Class A Common Stock's market cap, and MaxLinear Inc. Common Stock is trading nearer its 52-week high, Nuvation Bio Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold MaxLinear Inc. Common Stock for 1 Days and Nuvation Bio Inc. Class A Common Stock for 1 Days on average.
| MXL | NUVB | |
|---|---|---|
Market Cap | $8.50B | $1.74B |
Volume | 4,008,439 | 9,289,619 |
Sector | Technology | Health |
52-Week High | $128.03 | $9.54 |
52-Week Low | $13.05 | $3.41 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $8.58B | $1.33B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About MaxLinear Inc. Common Stock
MaxLinear develops analog and mixed-signal semiconductors for connectivity, communications, industrial, and data center applications.
Read more on MXL →About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →
